The DOI matches its Crossref record, with a small difference in title or year; 143 of the 144 references it cites were found in a registry or an index.
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects
Open accessAbstract
Atrial fibrillation (AF) remains the most common cardiac arrhythmia worldwide and is associated with significant morbidity and mortality. The European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) have recently released the 2024 guidelines for the management of AF. This review highlights 10 novel aspects of the ESC/EACTS 2024 Guidelines. The AF-CARE framework is introduced, a structural approach that aims to improve patient care and outcomes, comprising of four pillars: [C] Comorbidity and risk factor management, [A] Avoid stroke and thromboembolism, [R] Reduce symptoms by rate and rhythm control, and [E] Evaluation and dynamic reassessment. Additionally, graphical patient pathways are provided to enhance clinical application. A significant shift is the new emphasis on comorbidity and risk factor control to reduce AF recurrence and progression. Individualized assessment of risk is suggested to guide the initiation of oral anticoagulation to prevent thromboembolism. New guidance is provided for anticoagulation in patients with trigger-induced and device-detected sub-clinical AF, ischaemic stroke despite anticoagulation, and the indications for percutaneous/surgical left atrial appendage exclusion. AF ablation is a first-line rhythm control option for suitable patients with paroxysmal AF, and in specific patients, rhythm control can improve prognosis. The AF duration threshold for early cardioversion was reduced from 48 to 24 h, and a wait-and-see approach for spontaneous conversion is advised to promote patient safety. Lastly, strong emphasis is given to optimize the implementation of AF guidelines in daily practice using a patient-centred, multidisciplinary and shared-care approach, with the simultaneous launch of a patient version of the guideline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 AF-CARE framework. AF, atrial fibrillation; CARE, [C] Comorbidity and risk factor management, [A] Avoid stroke and thromboembolism, [R] Reduce symptoms by rate and rhythm control, [E] Evaluation and dynamic reassessment. Adapted from EHJ 2024.4](/paper-figures/058d1e56b3f6442fa6754132aedd0397/spotlight-on-the-2024-esc-eacts-management-of-atrial-fibrillation-guidelines-10-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The CHA2DS2-VA score is a reliable risk scale for prescribing oral anticoagulants (OAC) [88].”
From Atrial Fibrillation in Elite Athletes: A Comprehensive Review of the Literature (2024) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citationAhmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
Self-citationAtrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citationRuff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Cited by
Sorted by citations
Items 101–128 of 128
Faccenda, D., Bergonti, M., Potter, T. J. R. D., Haı̈ssaguerre, M., Saenen, J. B., de Asmundis, C., Ciconte, G., Riva, M., Casella, M., Costantino, J., et al. (2026) · EP Europace · doi:10.1093/europace/euag143
Stender, B. S., Eskildsen, V., Kramer, A. D., Hellfritzsch, M., Korsholm, K., Bonnesen, K., Schmidt, M., Kronborg, M. B., & Nielsen‐Kudsk, J. E. (2026) · EP Europace · doi:10.1093/europace/euag151
Boriani, G., Molon, G., Nardi, S., Mitacchione, G., Ricciardi, D., Chieffo, E., MANTOVAN, R., Bontempi, L., Martignani, C., Casella, M., et al. (2026) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-026-02392-w
Risks of discontinuation of anticoagulation after atrial fibrillation ablation in high-risk patients
Boriani, G., Botto, G. L., & Mei, D. A. (2026) · EP Europace · doi:10.1093/europace/euag154
Nayak, S. S., Amini‐Salehi, E., Letafatkar, N., Arya, A., Ghodous, S., Jafari, M., Nasrollahizadeh, A., Gurram, A., Nadali, J., Mirkalaie, S. M. M., et al. (2026) · EP Europace · doi:10.1093/europace/euag104
İşleyen, H. B., Yavuz, S. T., Bulut, S., Kızkapan, F., Alioglu, C., sunger, E., & Okuyan, E. (2026) · Cardio-Oncology · doi:10.1186/s40959-026-00548-1
Romiti, G. F., Corica, B., & Boriani, G. (2026) · EP Europace · doi:10.1093/europace/euag182
Zemmouchi, M., Fermawi, A. E., Benagdi, A., Baaziz, S., & Hiram, R. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119824
Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective
Wang, D., Ricke‐Hoch, M., Duncker, D., Bauersachs, J. K., & Berliner, D. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70590
Peng, X., He, L., Wang, J., Li, S., Li, Q., Zhao, Z., Yang, Z., Li, M., Li, F., Liu, X., et al. (2026) · EP Europace · doi:10.1093/europace/euag197
Current Status of Atrial Fibrillation Ablation Surgery
Ad, N., & Waterford, S. D. (2026) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezag208
Wang, D., Liewald, J., Karfoul, N., Müller‐Leisse, J., Hillmann, H. A. K., Immenschuh, S., Bauersachs, J. K., & Duncker, D. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2026.08.132
Danielian, A., & Singh, S. (2026) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-026-01153-2
Jia-ming, H., Fang-yi, Z., Niu, X.-H., Hu, J.-F., Fan, S., Ying, Z., & Ma, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1872678
Kim, Y., Lee, S. J., Park, Y., & Lee, K. (2026) · Diagnostics · doi:10.3390/diagnostics16172725
Khan, M., Skröder, S., Ingre, M., Carlstedt, F., Eriksson, A., Tenn, J. S., Rosenqvist, M., & Svennberg, E. (2026) · EP Europace · doi:10.1093/europace/euag214
Self-citationPavluk, D., Kindl, B., Pröll, S., Rockenschaub, P., Dolejsi, T., Lechner, I., Aumayer, H., Hofhansel, L., Rizas, K. D., Hayn, D., et al. (2026) · EP Europace · doi:10.1093/europace/euag192
Emara, A., Mansour, A., Hamed, B. M., Elbataa, A., Azim, A. A. A., Elkasaby, M. H., Awashra, A., Shubietah, A. R. M., Jabbar, A. B. A., Rmilah, A. A. A., et al. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001452
凌天佑, Lin, Y., Bao, Y., Chen, L., Xu, W., Tang, B., Xu, J., Zhong, J., Li, W., Ruan, Z., et al. (2026) · EP Europace · doi:10.1093/europace/euag230
Fateeva, V. V., Shindryaeva, N. N., & Ov, V. (2026) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202612608171
Leivaditis, V., Mulita, F., Koletsis, E. N., Androutsopoulou, V. A., Baikoussis, N. G., Mitsos, S., Papatriantafyllou, A., Tomos, P., & Dahm, M. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm57290
Identifying patients at low risk for atrial fibrillation after cryptogenic stroke: the PAVA score
Maille, B., Resseguier, N., Marijon, É., Béhar, N., Badoz, M., Vuillier, F., Malrain, C., Grygorowicz, C., Klein, V., Menet, A., et al. (2026) · EP Europace · doi:10.1093/europace/euag183
Wu, C. S., Chen, P., Lin, W., Liu, W.-T., Chan, P.-K., Wu, H. Y., Lin, C., Lin, W., & Lee, C. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.050723
Zhang, B., Wei, H., Ding, P., Chen, W., Shen, J., Xiaoqin, H., li, F., Ge, L., zhang, Q., wang, Z., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10876943/v1
Mantovani, M., Vitolo, M., Mei, D. A., Bonini, N., Trapanese, P., Tartaglia, E., Paolini, M., Orlandi, M., Imberti, J. F., & Boriani, G. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.10.011
The perspective of combining pulsed field ablation and left atrial appendage closure
Boersma, L. V. A., Potter, T. J. R. D., Heeger, C.-H. H., Nair, D. G., Roten, L., Schiavone, M., Tondo, C., Iozzia, P., Giabbani, I., Haddad, M., et al. (2026) · EP Europace · doi:10.1093/europace/euag202
Patel, D., Kallash, M., & Frishman, W. H. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001500
Massoullié, G., Chaumont, C., Laredo, M., Pereira, B., Thomas, O., Maury, P., Defaye, P., Bovéda, S., Marijon, É., Escande, W., et al. (2026) · EP Europace · doi:10.1093/europace/euag288
Metadata
- Authors
- Rienstra, M., Tzeis, S., Bunting, K. V., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Sanders, P., Svennberg, E., Casado-Arroyo, R., Dwight, J., Guasti, L., Hanke, T., Jaarsma, T., Lettino, M., Løchen, M.-L., Lumbers, R. T., Maesen, B., Mølgaard, I., Rosano, G. M. C., Schnabel, R. B., Suwalski, P., Tamargo, J., Tica, O., Traykov, V., Kotecha, D., & Van Gelder, I. C.
- Affiliations
- University Medical Center Groningen (NL)
- Mitera Hospital (GR)
- University of Birmingham (GB)
- University of Perugia (IT)
- Maastricht University Medical Centre (NL)
- Department of Cardiology, OLV Hospital , Aalst ,
- Royal Adelaide Hospital (AU)
- Karolinska University Hospital (SE)
- Department of Cardiology, H.U.B.-Hôpital Erasme, Université Libre de Bruxelles , Brussels ,
- European Society of Cardiology (FR)
- University of Insubria (IT)
- Asklepios Klinikum Harburg (DE)
- Linköping University (SE)
- Department for Cardiac, Thoracic and Vascular Diseases, Fondazione IRCCS San Gerardo dei Tintori , Monza ,
- University Hospital of North Norway (NO)
- University College Hospital (GB)
- ESC Patient Forum, Sophia Antipolis ,
- St George's, University of London (GB)
- Universität Hamburg (DE)
- National Medical Institute of the Ministry of Interior and Administration (PL)
- Universidad Complutense de Madrid (ES)
- Institute of Cardiovascular Sciences, University of Birmingham , Birmingham ,
- Tokuda Hospital (BG)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Department of Cardiology, University of Groningen, University Medical Center Groningen , P.O. Box 30.001, 9700 RB Groningen ,
- Corresponding author
- Rienstra, Michiel
- ORCID
- Rienstra, Michiel
- Tzeis, Stylianos
- Bunting, Karina V
- Caso, Valeria
- Crijns, Harry J G M
- De Potter, Tom J R
- Sanders, Prashanthan
- Svennberg, Emma
- Casado-Arroyo, Ruben
- Guasti, Luigina
- Hanke, Thorsten
- Jaarsma, Tiny
- Lettino, Maddalena
- Løchen, Maja-Lisa
- Lumbers, R Thomas
- Maesen, Bart
- Rosano, Giuseppe M C
- Schnabel, Renate B
- Suwalski, Piotr
- Tamargo, Juan
- Tica, Otilia
- Traykov, Vassil
- Kotecha, Dipak
- Van Gelder, Isabelle C
- Venue
- Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-12
- Volume
- 26
- Issue
- 12
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- PMC
- PMC11666470
- OpenAlex
- W4405728415
- Cited by
- 128
- References
- 144
- Citations by year
- 2026: 62 · 2025: 65 · 2024: 1
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- EP Europace (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by)
- St George's Online Research Archive (St George's University of London) (submittedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- IrInSubria (University of Insubria) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Funders
- Bayer
- InCarda Therapeutics
- Dutch Cardiovascular Alliance
- ZonMw
- Dutch Heart Foundation (848090001, 2018B017)
- Netherlands Cardiovascular Research Initiative
- Horizon 2020 (847770)
- Pfizer
- EVER Neuro Pharma
- Bayer AG
- Boehringer-Ingelheim
- Daiichi Sankyo
- Sanofi
- Roche Diagnostics
- Acesion Pharma
- Boston Scientific
- Biosense Webster
- Adagio Medical
- Abbott Vascular
- Medtronic
- CathRx
- Pacemate
- Boston Scientific, Medtronic, Abbott, and Becton Dickenson
- Astra Zeneca
- Johnson and Johnson
- Merck Sharp & Dohme
- St. Jude Medical
- Oxford University Press
- PassPACES
- Royal College of Physicians
- AtriCure
- BioVentrix
- Edwards Lifesciences
- Amarin Corporation
- Health Data Research UK
- Medical Research Council
- National Institutes of Health
- Pfizer Innovative Target Exploration Network
- HealthLumen
- Fitfile
- Norgine BV
- Danish Heart Association
- Vifor International
- Menarini Group
- AstraZeneca
- Abbott Laboratories
- European Research Council
- German Centre for Cardiovascular Research (81Z1710103, 81Z0710114)
- ERACoSysMed3 (031L0239)
- Horizon Europe (101095480)
- EU
- German Ministry for Research and Technology (BMBF 01ZX1408A)
- Bristol Myers Squibb
- Bayer HealthCare
- Sun Wave Pharma
- Teva Pharmaceutical Industries
- Biotronik
- National Institute for Health Research (NIHR CDF-2015-08-074 RATE-AF, NIHR130280 DaRe2THINK, NIHR132974 D2T-NeuroVascular, NIHR203326)
- British Heart Foundation (FS/CDRF/21/21032, PG/17/55/33087, AA/18/2/34218)
- Innovative Medicines Initiative
- EU Horizon
- R&D Subnational Secure Data Environment Programme
- Pioneer Fund
- Cook and Wolstenholme Charitable Trust
- European Society of Cardiology
- Biomedical Research Centre
- University of Birmingham
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- atrial fibrillation, oral anticoagulation, rate and rhythm control, left atrial appendage exclusion, atrial fibrillation ablation, paroxysmal atrial fibrillation, shared care, care pathways
- MeSH terms
- Anti-Arrhythmia Agents, Anticoagulants, Atrial Fibrillation, Cardiology, Europe, Humans, Risk Factors, Thromboembolism, Comorbidity, Treatment Outcome, Catheter Ablation, Practice Guidelines as Topic, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
